MedTrace Logo

Feasibility and Validation of a Standard Phenotyping Assessment Battery

NCT03495869 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 368

Last updated 2021-08-04

Study results available
· View outcomes & findings →

Summary

The overall goal of this project is to collect preliminary data on psychosocial measures and behavioral performance comparing individuals with Opioid Use Disorder, Cocaine Use Disorder, dual diagnosis of Opioid and Cocaine Use Disorder, and Healthy Controls in an effort to determine overall feasibility of a phenotypic "fingerprint" for cohorts of individuals with addictions for use during clinical trials.

Conditions

  • Opioid-use Disorder
  • Cocaine Use Disorder
  • Marijuana Use Disorder
  • Healthy Controls

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Virginia Commonwealth University

    lead OTHER

Principal Investigators

  • Lori Keyser-Marcus, PhD · Virginia Commonwealth University

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-21
Primary Completion
2020-03-16
Completion
2020-03-16

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03495869 on ClinicalTrials.gov